Susquehanna International Group
ERNAW

Susquehanna International Group’s Ernexa Therapeutics Warrants ERNAW Stock Holding History

Susquehanna International Group’s Portfolio ERNAW Stock Details ERNAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.13K Buy
+57,890
New +$5.49K ﹤0.01% 13204

Other funds holding ERNAW

BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $433M AUM 8.59% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
CS
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $551M AUM 34.68% 1-Year Est. Return

Susquehanna International Group's ERNAW Position: Q2 2026 in Review

Susquehanna International Group opened a new position in Ernexa Therapeutics Warrants (ERNAW) in Q2 2026: 57,890 shares worth $4.13K. The stake represents ﹤0.01% of the portfolio and ranks #13204 among its holdings.

6 funds tracked by Wall St. Rank hold ERNAW as of Q2 2026.

  • Susquehanna International Group held 57,890 shares of Ernexa Therapeutics Warrants worth $4.13K as of Q2 2026.
  • Ernexa Therapeutics Warrants was a new Susquehanna International Group position in Q2 2026.
  • Ernexa Therapeutics Warrants made up ﹤0.01% of Susquehanna International Group's portfolio in Q2 2026, its #13204 holding.
  • 6 funds tracked by Wall St. Rank held Ernexa Therapeutics Warrants as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.